{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:56:38Z","timestamp":1794855398408,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01590-x","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:56:37Z","timestamp":1776426997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A broad cathepsin inhibitor blocks crystal-stimulated inflammasome-dependent and -independent inflammation and gout arthritis"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-8488","authenticated-orcid":false,"given":"Laura Alejandra Ariza","family":"Orellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-4412","authenticated-orcid":false,"given":"Matthew","family":"Bogyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-3024","authenticated-orcid":false,"given":"Kenneth L.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5239-3992","authenticated-orcid":false,"given":"Jiann-Jyh","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-pharmtox-031023-125300","volume":"64","author":"Q Ma","year":"2024","unstructured":"Ma, Q. & Lim, C. S. Molecular activation of NLRP3 inflammasome by particles and crystals: a continuing challenge of immunology and toxicology. Annu. Rev. Pharm. Toxicol. 64, 417\u2013433 (2024).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"1590_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth, N., Gosling, A. L., Gaffo, A. & Abhishek, A. Gout. Lancet 397, 1843\u20131855 (2021).","journal-title":"Lancet"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2016.00097","volume":"7","author":"KM Pollard","year":"2016","unstructured":"Pollard, K. M. Silica, silicosis, and autoimmunity. Front Immunol. 7, 97 (2016).","journal-title":"Front Immunol."},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ajpath.2016.11.008","volume":"187","author":"JK Thompson","year":"2017","unstructured":"Thompson, J. K., MacPherson, M. B., Beuschel, S. L. & Shukla, A. Asbestos-induced mesothelial to fibroblastic transition is modulated by the inflammasome. Am. J. Pathol. 187, 665\u2013678 (2017).","journal-title":"Am. J. Pathol."},{"key":"1590_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"1590_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1055788","volume":"14","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. NLRP3 inflammasome activation in response to metals. Front Immunol. 14, 1055788 (2023).","journal-title":"Front Immunol."},{"key":"1590_CR7","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"CJ Chen","year":"2006","unstructured":"Chen, C. J. et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Investig. 116, 2262\u20132271 (2006).","journal-title":"J. Clin. Investig."},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674\u2013677 (2008).","journal-title":"Science"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1165\/rcmb.2021-0545TR","volume":"66","author":"M Lam","year":"2022","unstructured":"Lam, M., Mansell, A. & Tate, M. D. Another one fights the dust: targeting the NLRP3 inflammasome for the treatment of silicosis. Am. J. Respir. Cell Mol. Biol. 66, 601\u2013611 (2022).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ocl.2023.02.003","volume":"54","author":"HS Holbrook","year":"2023","unstructured":"Holbrook, H. S. & Calandruccio, J. H. Management of gout in the hand and wrist. Orthop. Clin. North Am. 54, 299\u2013308 (2023).","journal-title":"Orthop. Clin. North Am."},{"key":"1590_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mcna.2020.09.013","volume":"105","author":"SF Keller","year":"2021","unstructured":"Keller, S. F. & Mandell, B. F. Management and cure of gouty arthritis. Med. Clin. North Am. 105, 297\u2013310 (2021).","journal-title":"Med. Clin. North Am."},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","volume":"22","author":"G Lopez-Castejon","year":"2011","unstructured":"Lopez-Castejon, G. & Brough, D. Understanding the mechanism of IL-1beta secretion. Cytokine Growth Factor Rev. 22, 189\u2013195 (2011).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1590_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep45126","volume":"7","author":"SM Man","year":"2017","unstructured":"Man, S. M. et al. Differential roles of caspase-1 and caspase-11 in infection and inflammation. Sci. Rep. 7, 45126 (2017).","journal-title":"Sci. Rep."},{"key":"1590_CR14","first-page":"cm2","volume":"3","author":"A Weber","year":"2010","unstructured":"Weber, A., Wasiliew, P. & Kracht, M. Interleukin-1beta (IL-1beta) processing pathway. Sci. Signal 3, cm2 (2010).","journal-title":"Sci. Signal"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.bj.2023.100655","volume":"47","author":"SS Madahar","year":"2023","unstructured":"Madahar, S. S., Gideon, A. & Abdul-Sater, A. A. Nod-like receptors in inflammatory arthritis. Biomed. J. 47, 100655 (2023).","journal-title":"Biomed. J."},{"key":"1590_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-017-0050-9","volume":"37","author":"T Karasawa","year":"2017","unstructured":"Karasawa, T. & Takahashi, M. The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis. Inflamm. Regen. 37, 18 (2017).","journal-title":"Inflamm. Regen."},{"key":"1590_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2023","unstructured":"Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595\u2013600 (2023).","journal-title":"Nature"},{"key":"1590_CR18","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y. & He, Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 20 (2019).","DOI":"10.3390\/ijms20133328"},{"key":"1590_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1590_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"1590_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.abb.2019.02.015","volume":"670","author":"RI Campden","year":"2019","unstructured":"Campden, R. I. & Zhang, Y. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Arch. Biochem. Biophys. 670, 32\u201342 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"1590_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4049\/jimmunol.1500509","volume":"195","author":"GM Orlowski","year":"2015","unstructured":"Orlowski, G. M. et al. Multiple cathepsins promote Pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation. J. Immunol. 195, 1685\u20131697 (2015).","journal-title":"J. Immunol."},{"key":"1590_CR23","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.4049\/jimmunol.0802367","volume":"182","author":"NB Bryan","year":"2009","unstructured":"Bryan, N. B., Dorfleutner, A., Rojanasakul, Y. & Stehlik, C. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J. Immunol. 182, 3173\u20133182 (2009).","journal-title":"J. Immunol."},{"key":"1590_CR24","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1073\/pnas.1318688111","volume":"111","author":"JR Lukens","year":"2014","unstructured":"Lukens, J. R. et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc. Natl. Acad. Sci. USA 111, 1066\u20131071 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1590_CR25","doi-asserted-by":"crossref","unstructured":"Chan, A. H. & Schroder, K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J. Exp. Med. 217 (2020).","DOI":"10.1084\/jem.20190314"},{"key":"1590_CR26","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.celrep.2018.02.062","volume":"22","author":"DM Clancy","year":"2018","unstructured":"Clancy, D. M. et al. Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36 cytokine activity but poor effectors of microbial killing. Cell Rep. 22, 2937\u20132950 (2018).","journal-title":"Cell Rep."},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.4049\/jimmunol.1200136","volume":"189","author":"H Kono","year":"2012","unstructured":"Kono, H., Orlowski, G. M., Patel, Z. & Rock, K. L. The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C. J. Immunol. 189, 3734\u20133740 (2012).","journal-title":"J. Immunol."},{"key":"1590_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"1590_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0162-3109(97)00034-9","volume":"36","author":"L Troeberg","year":"1997","unstructured":"Troeberg, L., Pike, R. N., Lonsdale-Eccles, J. D. & Coetzer, T. H. Production of anti-peptide antibodies against trypanopain-Tb from Trypanosoma brucei brucei: effects of antibodies on enzyme activity against Z-Phe-Arg-AMC. Immunopharmacology 36, 295\u2013303 (1997).","journal-title":"Immunopharmacology"},{"key":"1590_CR30","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.biochi.2010.04.023","volume":"92","author":"BT Elie","year":"2010","unstructured":"Elie, B. T. et al. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie 92, 1618\u20131624 (2010).","journal-title":"Biochimie"},{"key":"1590_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.celrep.2016.06.011","volume":"16","author":"TC Tzeng","year":"2016","unstructured":"Tzeng, T. C. et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep. 16, 571\u2013582 (2016).","journal-title":"Cell Rep."},{"key":"1590_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.4049\/jimmunol.129.4.1589","volume":"129","author":"LR DeChatelet","year":"1982","unstructured":"DeChatelet, L. R. et al. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J. Immunol. 129, 1589\u20131593 (1982).","journal-title":"J. Immunol."},{"key":"1590_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nm.1886","volume":"15","author":"S Gross","year":"2009","unstructured":"Gross, S. et al. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med 15, 455\u2013461 (2009).","journal-title":"Nat. Med"},{"key":"1590_CR34","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1073\/pnas.0803933105","volume":"105","author":"SL Cassel","year":"2008","unstructured":"Cassel, S. L. et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. USA 105, 9035\u20139040 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1590_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nm.2403","volume":"17","author":"T Marichal","year":"2011","unstructured":"Marichal, T. et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med 17, 996\u20131002 (2011).","journal-title":"Nat. Med"},{"key":"1590_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep07281","volume":"4","author":"A Hari","year":"2014","unstructured":"Hari, A. et al. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci. Rep. 4, 7281 (2014).","journal-title":"Sci. Rep."},{"key":"1590_CR37","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4161\/cc.24903","volume":"12","author":"H Lima Jr.","year":"2013","unstructured":"Lima, H. Jr. et al. Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle 12, 1868\u20131878 (2013).","journal-title":"Cell Cycle"},{"key":"1590_CR38","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720\u20133732 (2011).","journal-title":"Blood"},{"key":"1590_CR39","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/S0021-9258(18)53798-4","volume":"268","author":"MJ McGuire","year":"1993","unstructured":"McGuire, M. J., Lipsky, P. E. & Thiele, D. L. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J. Biol. Chem. 268, 2458\u20132467 (1993).","journal-title":"J. Biol. Chem."},{"key":"1590_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI0213462","volume":"109","author":"AM Adkison","year":"2002","unstructured":"Adkison, A. M., Raptis, S. Z., Kelley, D. G. & Pham, C. T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest 109, 363\u2013371 (2002).","journal-title":"J. Clin. Invest"},{"key":"1590_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","volume":"124","author":"RT Keenan","year":"2011","unstructured":"Keenan, R. T. et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am. J. Med 124, 155\u2013163 (2011).","journal-title":"Am. J. Med"},{"key":"1590_CR42","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5, e11765 (2010).","journal-title":"PLoS One"},{"key":"1590_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1590_CR44","doi-asserted-by":"publisher","first-page":"175909142091855","DOI":"10.1177\/1759091420918557","volume":"12","author":"T Bartfai","year":"2020","unstructured":"Bartfai, T. & Lees, G. V. Alzheimer drug trials: combination of safe and efficacious biologicals to break the amyloidosis-neuroinflammation vicious cycle. ASN Neuro 12, 1759091420918557 (2020).","journal-title":"ASN Neuro"},{"key":"1590_CR45","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa, M. et al. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer\u2019s disease model. J. Immunol. 187, 6539\u20136549 (2011).","journal-title":"J. Immunol."},{"key":"1590_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","volume":"75","author":"Q Ma","year":"2023","unstructured":"Ma, Q. Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction. Pharm. Rev. 75, 487\u2013520 (2023).","journal-title":"Pharm. Rev."},{"key":"1590_CR47","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid, A., Li, B., Kombe, A. J. K., Jin, T. & Tao, J. Pharmacological Inhibitors of the NLRP3 Inflammasome. Front. Immunol. 10, 2538 (2019).","journal-title":"Front. Immunol."},{"key":"1590_CR48","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kluck","year":"2020","unstructured":"Kluck, V. et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2, e270\u2013e280 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1590_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fmed.2020.00166","volume":"7","author":"F Oliviero","year":"2020","unstructured":"Oliviero, F. et al. Autoinflammatory mechanisms in crystal-induced arthritis. Front. Med. 7, 166 (2020).","journal-title":"Front. Med."},{"key":"1590_CR50","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","volume":"7","author":"MR McClung","year":"2019","unstructured":"McClung, M. R. et al. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diab. Endocrinol. 7, 899\u2013911 (2019).","journal-title":"Lancet Diab. Endocrinol."},{"key":"1590_CR51","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1093\/rheumatology\/kead092","volume":"62","author":"D Bentley","year":"2023","unstructured":"Bentley, D., Fisher, B. A., Barone, F., Kolb, F. A. & Attley, G. A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjogren\u2019s syndrome. Rheumatol. 62, 3644\u20133653 (2023).","journal-title":"Rheumatol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01590-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:02:03Z","timestamp":1781658123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01590-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.01.601464","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"345"}}